Skip to content

Effects of Rehabilitation for Patients With Obstructive Sleep Apnea

Effects of Rehabilitation for Patients With Obstructive Sleep Apnea

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03940781
Enrollment
33
Registered
2019-05-07
Start date
2017-09-01
Completion date
2019-03-22
Last updated
2019-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea of Adult

Keywords

obstructive sleep apnea, oropharyngeal rehabilitation, cardiopulmonary rehabilitation

Brief summary

In previous review study, it was hypothesized that a comprehensive rehabilitation can combine both local pharyngeal muscle exercise and systemic cardiopulmonary rehabilitation for the OSA patients with oropharyngeal muscle dysfunction or ventilator drive instability. To develop a comprehensive rehabilitation model is of innovative care strategy in this study.

Detailed description

BACKGROUND: Obstructive sleep apnea (OSA) is a prevalent sleep-related breathing disorder, which was characterized by repetitive events of complete and partial obstructions of the upper airway. The pathogenesis of OSA is interacted by multiple factors, primarily including upper airway (UA) anatomic impairment, ventilatory drive instability, and oropharyngeal muscle dysfunction. However, studies have proven prior oropharyngeal exercise was designed for those OSA patients with oropharyngeal muscle dysfunction. Unlike prior oropharyngeal exercise, comprehensive rehabilitation should emphasize the cardiorespiratory regulation capability in addition to oropharyngeal function. OBJECTIVES: Therefore, the purpose of this study is to explore both the clinical and biological effects of our comprehensive rehabilitation, we used PSG data as clinical effect and biomarker of inflammation expression as biological effect. METHODS: Thirty subjects with moderate or severe OSA (AHI≥15) were randomized into intervention group (N=15) and control group (N=15). In intervention group, a 12-week-intervention of out-patient rehabilitation program included oropharyngeal muscle training, threshold respiratory muscle training, and therapeutic exercise. ANTICIPATED OUTCOMES: The preliminary results would demonstrate promisingly clinical effects and biological effects of our comprehensive rehabilitation model. Therefore, the further studies should emphasize the methods to differentiate diagnosis for the indicated patients with oropharyngeal muscle dysfunction or ventilatory drive instability.

Interventions

oropharyngeal rehabilitation, cardiopulmonary rehabilitation, and therapeutic exercise

Sponsors

National Cheng-Kung University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

participants and assessors blinded

Intervention model description

30 participants with moderate or severe OSA (AHI≥15) were randomized into intervention group (N=15) and control group (N=15).

Eligibility

Sex/Gender
ALL
Age
35 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged 35-65 with or without surgery had difficulty accepting or adhering CPAP

Exclusion criteria

* BMI\<32 * Smoking or alcoholism * Severe allergic rhinitis * Stroke history * CVD * Severe restricted or obstructive pulmonary disease * Hypothyroidism * DM or HTN without stable control * Psychiatric disease * Co-existing non-respiratory sleep disorders

Design outcomes

Primary

MeasureTime frameDescription
Apnea-hypopea-indexChange from Baseline Apnea-hypopnea-index at 12 weeksaverage apnea and hypopnea events per hour during sleep test
potential biomarkers of endothelial dysfunctionat 12 weekscount of ICAM-1, VCAM-1, and NF-κB molecule in plasma serum (%)

Secondary

MeasureTime frameDescription
Oropharyngeal muscle functionat 12 weeksmyofunctional scale of genioglossus muscles, mastication muscles, and deglultition muscles
Respiratory muscle functionat 12 weeksPImax(mmH2O), PEmax(mmH2O)
Hear rate variabilityat 12 weekstime domain and frequency domain HRV

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026